Other Clinical Trial - Efficacy of the Digital Platform for Diabetes Care

Status Completed

Clinical Trial Summary

Introduction: In patients diagnosed with DM2, it is essential to achieve good metabolic control. One of the tools to optimize said control is self-monitoring with capillary glucometry or SMBG (Self Monitoring of Blood Glucose), which is indicated in all patients treated with insulin and is part of the "treat to target" strategies associated with education. Despite this, many patients do not perform self-titration of insulin due to the number of capillary glucose measurements (CG) necessary, or they do not record them adequately, which leads to therapeutic inertia. Digital platforms integrated with the use of smart mobile devices facilitate this process, and in experimental settings, they have shown a significant decrease in glycosylated hemoglobin (HbA1c) and an increase in adherence to therapy. However, at the moment there are no data about the efficacy of this system in the real population. Objective: To determine the effectiveness of the use of a digital platform for diabetes care, in terms of HbA1c reduction, compared with the usual treatment, in patients with DM2 under follow-up in a chronic patient care center. Methodology: A controlled clinical study will be carried out. Patients with a diagnosis of DM2, under follow-up in specialized centers, with poor glycemic control defined by HbA1c outside the goals and who have been discharged from a high complexity hospital will be included. Demographic, clinical, and insulin requirement variables will be recorded according to the total daily dose of insulin (DDT) in units. They will be randomly distributed into two groups; the intervention group will use SMBG integrated with a digital platform for diabetes care and the control group will use SMBG associated with usual care for 3 months. A comparison will be made between HbA1c levels, the number of episodes of severe hypoglycemia, nocturnal hypoglycemia, at baseline and 3 months.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Diabetes Mellitus
Diabetes Mellitus, Type 2
Type 2 Diabetes Treated With Insulin

Clinical Trial Details

NCT number	NCT05372471
Study type	Interventional
Source	Hospital Universitario San Ignacio
Contact
Status	Completed
Phase	N/A
Start date	October 1, 2020
Completion date	August 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04522882` - Clinical Data Collection for the Closed Loop Development for the Type 2 Diabetes Treatment - DT2_1	N/A
Completed	`NCT04274660` - Evaluation of Diabetes and WELLbeing Programme	N/A
Not yet recruiting	`NCT05185518` - Assessment of an Integrated Continuous Glucose Monitor and Insulin Injection Port in Type 2 Diabetes	N/A
Recruiting	`NCT05893797` - A Study of LY8888AX in Participants Using a Connected Insulin Management Platform	N/A
Completed	`NCT02791295` - Lifestyle Intervention in Type 2 Diabetes	N/A
Withdrawn	`NCT04957173` - Intensive Lifestyle Intervention in Patients With Insulin-treated Type 2 Diabetes: a Pilot Project	N/A
Not yet recruiting	`NCT05317585` - Continuous Glucose Monitor Use in Pregnancy	N/A
Completed	`NCT05111301` - Control-IQ Technology in Individuals With Type 2 Diabetes	N/A
Active, not recruiting	`NCT04585191` - Reducing Treatment Risk in Older Adults With Diabetes	N/A
Recruiting	`NCT04871438` - Flash CONtinous Glucose Monitoring in TRansition to Outpatient: Libre for Type 2 Diabetes Mellitus (CONTROL-DM)	N/A
Completed	`NCT06060743` - Examining the Effect of Mobile Application on Insulin Use Perception and Self-Management	N/A
Completed	`NCT04005261` - C-peptide Concentrations in Type 2 Diabetes Treated With Insulin; is it Time to Revise the Treatment of Type 2 Diabetes
Terminated	`NCT03980236` - Feasibility of Using the Livongo-Insulia Study App for Patients With Type 2 Diabetes [Pilot Study]	N/A
Not yet recruiting	`NCT06185296` - The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy	N/A
Completed	`NCT03437525` - Peer Support in Diabetes Management - Insulin Peer Support	N/A
Active, not recruiting	`NCT03070106` - Diabetes: Functional Medicine Approach vs. Usual Care	N/A
Completed	`NCT02060916` - Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 Diabetes	Phase 2
Active, not recruiting	`NCT05785832` - A Randomized Trial Evaluating Control-IQ Technology in Adults With Type 2 Diabetes	N/A
Recruiting	`NCT04945070` - INSULIN THERAPY DE-INTENSIFICATION WITH iGlarLixi	Phase 4
Recruiting	`NCT05795439` - The CARING Study: Creating and Restoring Health Through Nutrition Guidance	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Efficacy of the Digital Platform for Diabetes Care Compared to Usual Care in Patients Diagnosed With Type 2 Diabetes.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms